HRT Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Sell |
68,262
-292,480
| -81% | -$501K | ﹤0.01% | 1876 |
|
|
2025
Q1 | $1.2M | Buy |
+360,742
| New | +$1.2M | 0.01% | 893 |
|
|
2024
Q3 | – | Sell |
-70,967
| Closed | -$569K | – | 2576 |
|
|
2024
Q2 | $569K | Sell |
70,967
-225,207
| -76% | -$1.81M | ﹤0.01% | 1135 |
|
|
2024
Q1 | $4.39M | Buy |
296,174
+1,411
| +0.5% | +$20.9K | 0.03% | 289 |
|
|
2023
Q4 | $2.4M | Buy |
+294,763
| New | +$2.4M | 0.02% | 537 |
|
|
2023
Q2 | – | Sell |
-267,997
| Closed | -$1.64M | – | 2636 |
|
|
2023
Q1 | $1.64M | Buy |
+267,997
| New | +$1.64M | 0.02% | 667 |
|
|
2022
Q4 | – | Sell |
-139,467
| Closed | -$1.34M | – | 2581 |
|
|
2022
Q3 | $1.34M | Buy |
+139,467
| New | +$1.34M | 0.01% | 738 |
|
|
2022
Q2 | – | Sell |
-212,974
| Closed | -$3.55M | – | 3149 |
|
|
2022
Q1 | $3.55M | Buy |
212,974
+147,460
| +225% | +$2.46M | 0.03% | 366 |
|
|
2021
Q4 | $1.25M | Sell |
65,514
-6,190
| -9% | -$118K | 0.01% | 826 |
|
|
2021
Q3 | $1.77M | Buy |
+71,704
| New | +$1.77M | 0.01% | 738 |
|
|
2021
Q1 | – | Sell |
-80,965
| Closed | -$3.76M | – | 2680 |
|
|
2020
Q4 | $3.76M | Buy |
+80,965
| New | +$3.76M | 0.08% | 182 |
|
|
2020
Q3 | – | Sell |
-112,098
| Closed | -$3.08M | – | 2010 |
|
|
2020
Q2 | $3.08M | Buy |
+112,098
| New | +$3.08M | 0.09% | 215 |
|